213 related articles for article (PubMed ID: 37351797)
1. Preferences for Adjuvant Immunotherapy in Adults with Resected Stage III Melanoma-A Discrete Choice Experiment.
Livingstone A; Howard K; Menzies AM; Long GV; Stockler MR; Morton RL
Patient; 2023 Sep; 16(5):497-513. PubMed ID: 37351797
[TBL] [Abstract][Full Text] [Related]
2. Should I Have Adjuvant Immunotherapy? An Interview Study Among Adults with Resected Stage 3 Melanoma and Their Partners.
Livingstone A; Milne D; Dempsey K; Muscat DM; Menzies AM; Howard K; Stockler MR; Morton RL
Patient; 2021 Sep; 14(5):635-647. PubMed ID: 33759137
[TBL] [Abstract][Full Text] [Related]
3. Patient Preferences for Preventive Migraine Treatments: A Discrete-Choice Experiment.
Mansfield C; Gebben DJ; Sutphin J; Tepper SJ; Schwedt TJ; Sapra S; Shah N
Headache; 2019 May; 59(5):715-726. PubMed ID: 30861110
[TBL] [Abstract][Full Text] [Related]
4. The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment.
Braam SC; de Bruin JP; Mol BWJ; van Wely M
Hum Reprod Open; 2020; 2020(2):hoz034. PubMed ID: 32123754
[TBL] [Abstract][Full Text] [Related]
5. What Features of Fertility Treatment do Patients Value? Price Elasticity and Willingness-to-Pay Values from a Discrete Choice Experiment.
Keller E; Botha W; Chambers GM
Appl Health Econ Health Policy; 2023 Jan; 21(1):91-107. PubMed ID: 36171511
[TBL] [Abstract][Full Text] [Related]
6. Line of therapy and patient preferences regarding lung cancer treatment: a discrete-choice experiment.
Janse S; Janssen E; Huwig T; Basu Roy U; Ferris A; Presley CJ; Bridges JFP
Curr Med Res Opin; 2021 Apr; 37(4):643-653. PubMed ID: 33571024
[TBL] [Abstract][Full Text] [Related]
7. Assessing couples' preferences for fresh or frozen embryo transfer: a discrete choice experiment.
Abdulrahim B; Scotland G; Bhattacharya S; Maheshwari A
Hum Reprod; 2021 Oct; 36(11):2891-2903. PubMed ID: 34550368
[TBL] [Abstract][Full Text] [Related]
8. Patient preferences and willingness to pay for central venous access devices in breast cancer: A multicenter discrete choice experiment.
Liu S; Xiang Y; Gu Y; Chen N; Fu P; Wei Y; Zhao P; Li Y; Du C; Mu W; Xia Z; Chen Y
Int J Nurs Stud; 2024 Apr; 152():104695. PubMed ID: 38301304
[TBL] [Abstract][Full Text] [Related]
9. Association of Preferences for Papillary Thyroid Cancer Treatment With Disease Terminology: A Discrete Choice Experiment.
Nickel B; Howard K; Brito JP; Barratt A; Moynihan R; McCaffery K
JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):887-896. PubMed ID: 30140909
[TBL] [Abstract][Full Text] [Related]
10. Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia.
Snoswell CL; Whitty JA; Caffery LJ; Loescher LJ; Gillespie N; Janda M
J Telemed Telecare; 2018 Dec; 24(10):683-689. PubMed ID: 30343653
[TBL] [Abstract][Full Text] [Related]
11. Adolescent, parent and societal preferences and willingness to pay for meningococcal B vaccine: A Discrete Choice Experiment.
Marshall HS; Chen G; Clarke M; Ratcliffe J
Vaccine; 2016 Jan; 34(5):671-677. PubMed ID: 26740249
[TBL] [Abstract][Full Text] [Related]
12. Patients prioritize local recurrence risk over other attributes for surgical treatment of facial melanomas-Results of a stated preference survey and choice-based conjoint analysis.
Etzkorn JR; Tuttle SD; Lim I; Feit EM; Sobanko JF; Shin TM; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Aug; 79(2):210-219.e3. PubMed ID: 29505861
[TBL] [Abstract][Full Text] [Related]
13. Patient preference for a long-acting recombinant FSH product in ovarian hyperstimulation in IVF: a discrete choice experiment.
van den Wijngaard L; Rodijk IC; van der Veen F; Gooskens-van Erven MH; Koks CA; Verhoeve HR; Mol BW; van Wely M; Mochtar MH
Hum Reprod; 2015 Feb; 30(2):331-7. PubMed ID: 25432926
[TBL] [Abstract][Full Text] [Related]
14. How do women trade-off benefits and risks in chemotherapy treatment decisions based on gene expression profiling for early-stage breast cancer? A discrete choice experiment.
Marshall DA; Deal K; Bombard Y; Leighl N; MacDonald KV; Trudeau M
BMJ Open; 2016 Jun; 6(6):e010981. PubMed ID: 27256091
[TBL] [Abstract][Full Text] [Related]
15. Patient preferences for anti-hyperglycaemic medication for type 2 diabetes mellitus in China: findings from a national survey.
Liu S; Liu J; Si L; Ke X; Liu L; Ren Y; Bao S; Li F; Yu Y; Pan Q; Wei Y; Chen Y
BMJ Glob Health; 2023 Apr; 8(4):. PubMed ID: 37041021
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews.
Livingstone A; Dempsey K; Stockler MR; Howard K; Long GV; Carlino MS; Menzies AM; Morton RL
BMC Cancer; 2021 Sep; 21(1):1014. PubMed ID: 34507552
[TBL] [Abstract][Full Text] [Related]
17. Preferences of Canadian patients and physicians for adjuvant treatments for melanoma.
Stellato D; Thabane M; Eichten C; Delea TE
Curr Oncol; 2019 Dec; 26(6):e755-e765. PubMed ID: 31896946
[TBL] [Abstract][Full Text] [Related]
18. Patient preferences and predicted relative uptake for targeted therapies in metastatic colorectal cancer: a discrete choice experiment.
Wong XY; Lim AQJ; Shen Q; Chia JWK; Chew MH; Tan WS; Wee HL
Curr Med Res Opin; 2020 Oct; 36(10):1677-1686. PubMed ID: 32609014
[TBL] [Abstract][Full Text] [Related]
19. Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center.
Stenehjem DD; Au TH; Ngorsuraches S; Ma J; Bauer H; Wanishayakorn T; Nelson RS; Pfeiffer CM; Schwartz J; Korytowsky B; Oderda G; Brixner DI
Melanoma Res; 2019 Dec; 29(6):626-634. PubMed ID: 30688762
[TBL] [Abstract][Full Text] [Related]
20. Exploring the Preferences of the Australian Public for Antibiotic Treatments: A Discrete Choice Experiment.
Degeling C; Yarwood T; Nettel-Aguirre A; Mullan J; Reynolds N; Chen G
Patient; 2023 Sep; 16(5):555-567. PubMed ID: 37462880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
